Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,8013,820 of 20,252 grants

Active NON-SBIR/STTR RPGS
Transcriptional Regulation in ZFTA-RELA Ependymoma
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2023 – 2028

SUMMARY Transcriptional networks in cancer are a collection of inputs from developmental and cell identity programs, oncogenic proteins, metabolic circuits, and micro-environmental...

$6.64M
USD
Active NON-SBIR/STTR RPGS
Southwest EDRN Clinical Validation Center for Head and Neck Cancer
NATIONAL CANCER INSTITUTE Arizona State University-Tempe Campus United States 2023 – 2028

Project Summary/Abstract The goal of the EDRN Southwest Clinical Validation Center for Head and Neck Cancer is to improve oropharyngeal cancerscreening through the rigorous validat...

$9.63M
USD
Completed NON-SBIR/STTR RPGS
Inducing Tumor Neoantigens Through RNA Editing for Cancer Immunotherapy
NATIONAL CANCER INSTITUTE University of Chicago United States 2023 – 2025

PROJECT SUMMARY/ABSTRACT Immune checkpoint inhibitors (ICIs) have revolutionized cancer immunotherapy but remain effective in only a subset of patients and tumor types. The success...

$1.84M
USD
Active TRAINING, INDIVIDUAL
Novel Triple-Negative Breast cancer vulnerability governed by PNPT1-mediated RNA decay
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2023 – 2027

PROJECT SUMMARY / ABSTRACT Breast cancer is the most common cancer and the leading cause of cancer death in females. Triple negative breast cancer (TNBC) is a highly aggressive and...

$498.2K
USD
Active NON-SBIR/STTR RPGS
Elucidating the SCP4 pathway as a multi-catalytic signaling dependency in acute myeloid leukemia
NATIONAL CANCER INSTITUTE Cold Spring Harbor Laboratory United States 2023 – 2028

PROJECT SUMMARY Phosphatases and kinases are established classes of drug targets in oncology due to the presence of structured catalytic pockets or allosteric sites that can be tar...

$6.69M
USD
Active NON-SBIR/STTR RPGS
HLA B44 motif neoepitopes in NSCLC: Evaluating their effects on the TME and adding them to established markers in a model to predict durable benefit from PD- 1 inhibition with and without chemotherapy
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2023 – 2028

PROJECT SUMMARY Lung cancer is the leading cause of cancer related deaths in the United States and the World. We recently demonstrated that programmed cell death 1 (PD-1) inhibitor...

$2.25M
USD
Active OTHER RESEARCH-RELATED
Leveraging Health Systems to Increase Implementation of Evidence-based Surgical Cancer Care
NATIONAL CANCER INSTITUTE University of Alabama At Birmingham United States 2023 – 2028

PROJECT SUMMARY Hospitals are increasingly consolidating into health systems with shared ownership and management. Care in a health system has potential benefits for surgical cance...

$1.97M
USD
Active NON-SBIR/STTR RPGS
RepurPosed AntiretrOviraL ThErapieS to EliminAte Cervical Cancer (POLESA Trial)
NATIONAL CANCER INSTITUTE University of Cincinnati United States 2023 – 2028

R37CA284033In the absence of cytology- and HPV-based cervical cancer screening, screening of the cervix by visual inspection after application of acetic acid (VIA) to highlight pre...

$4.56M
USD
Active NON-SBIR/STTR RPGS
Utilizing Multi-omics to Facilitate Cancer Biology Research
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2023 – 2028

Project Summary As a member of the E. Alejandro Sweet-Cordero laboratory my efforts are directed at executing the computational aspects of the grants, manuscripts, and the general...

$2.34M
USD
Completed NON-SBIR/STTR RPGS
Role of a latent OriLyt RNA in KSHV latency in primary effusion lymphoma
NATIONAL CANCER INSTITUTE University of Arkansas for Med Scis United States 2023 – 2025

Project Summary The Kaposi's sarcoma-associated herpesvirus (KSHV) causes the AIDS-defining B cell malignancy, primary effusion lymphoma (PEL). KSHV is found in all tumor cell...

$1.79M
USD
Active NON-SBIR/STTR RPGS
Defining the Biological Arc of Grade Group 1 Prostate Cancer
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2023 – 2028

The long-term goal of this project is to further reduce the biological uncertainty associated with surveillance for favorable-risk prostate cancer. Although most men with favorable...

$3.39M
USD
Active NON-SBIR/STTR RPGS
Targeting the BCL2 immune checkpoint to enhance the immunostimulatory effects of radiation in breast cancer
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2023 – 2028

SUMMARY Hormone receptor (HR)+ breast cancer (BC) causes the majority of BC-related deaths in the US, reflecting an unmet need for innovative therapeutic approaches. Indeed, resist...

$6.68M
USD
Active NON-SBIR/STTR RPGS
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Lung cancer is the leading cause of cancer death in the United States, and lung cancer screening has been demonstrated to effectively reduce lung cancer by...

$5.5M
USD
Active TRAINING, INDIVIDUAL
Elucidating the distinct roles of T cell-polarized microglia in glioblastoma suppression and progression
NATIONAL CANCER INSTITUTE Salk Institute for Biological Studies United States 2023 – 2027

Project Summary/Abstract Glioblastoma is a grade IV diffuse astrocytoma, the deadliest and most common form of adult brain cancer. Standard of care extends survival by approximatel...

$401.9K
USD
Completed OTHER RESEARCH-RELATED
The Hematologic Malignancies Conference
NATIONAL CANCER INSTITUTE Federation of Amer Soc for Exper Biology United States 2023 – 2024

SUMMARY/ABSTRACT The goal of this R13 application is to provide partial support to the 2023 Scientific Research Conference on Hematologic Malignancies administered by the Federatio...

$389K
USD
Active NON-SBIR/STTR RPGS
Pathway-guided treatment of immune checkpoint inhibitor therapy-induced colon toxicity
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2023 – 2028

Abstract Development of immune-related adverse effects (irAEs) is one of the significant challenges of current approved cancer therapy with immune checkpoint inhibitors (ICIs) of t...

$6.64M
USD
Active NON-SBIR/STTR RPGS
Elucidating the SCP4 pathway as a multi-catalytic signaling dependency in acute myeloid leukemia
NATIONAL CANCER INSTITUTE Cold Spring Harbor Laboratory United States 2023 – 2028

PROJECT SUMMARY Phosphatases and kinases are established classes of drug targets in oncology due to the presence of structured catalytic pockets or allosteric sites that can be tar...

$7.43M
USD
Active NON-SBIR/STTR RPGS
Bionic Breast Project: A Neuroprosthesis to Restore Touch Sensation and Reduce Chronic Pain After Mastectomy
NATIONAL CANCER INSTITUTE University of Chicago United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Millions of women worldwide have undergone mastectomy and breast reconstruction procedures. Simple (also called total) mastectomy, the most common mastecto...

$8.44M
USD
Completed TRAINING, INDIVIDUAL
Mechanisms of REST-mediated immunosuppression in cancer
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2023 – 2025

Project Abstract Tumor-intrinsic factors in cancer cells modulate the immune milieu to enable prolonged survival and growth of tumors. In breast cancer (BC), the 2nd leading cause...

$690.8K
USD
Completed TRAINING, INDIVIDUAL
The role of PTEN in epigenetic and metabolic regulation of IDH-mutant gliomas
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2023 – 2024

ABSTRACT Astrocytic tumors of the central nervous system (CNS) are intractable tumors and harbor dismal outcomes due to a lack of targeted treatment options. More than 70% of astro...

$362.9K
USD